
Hua Jasmine Song
Examiner (ID: 5920, Phone: (571)272-4213 , Office: P/2133 )
| Most Active Art Unit | 2133 |
| Art Unit(s) | 2187, 2188, 2189, 2133, 2138, 2131 |
| Total Applications | 1406 |
| Issued Applications | 1267 |
| Pending Applications | 70 |
| Abandoned Applications | 80 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4943720
[patent_doc_number] => 20080081045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-03
[patent_title] => 'Combination Therapy for Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/575618
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19425
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20080081045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575618 | Combination Therapy for Cancer | Oct 13, 2004 | Abandoned |
Array
(
[id] => 7192665
[patent_doc_number] => 20050163709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes'
[patent_app_type] => utility
[patent_app_number] => 10/955119
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 29906
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10955119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/955119 | Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes | Sep 29, 2004 | Abandoned |
Array
(
[id] => 6939148
[patent_doc_number] => 20050112711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Diagnosis and monitoring of hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 10/934520
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6754
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934520 | Diagnosis and monitoring of hepatocellular carcinoma | Sep 2, 2004 | Abandoned |
Array
(
[id] => 4522160
[patent_doc_number] => 07951528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-31
[patent_title] => 'Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system'
[patent_app_type] => utility
[patent_app_number] => 11/660070
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6181
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/951/07951528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660070
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660070 | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system | Aug 12, 2004 | Issued |
Array
(
[id] => 7252119
[patent_doc_number] => 20050074798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer'
[patent_app_type] => utility
[patent_app_number] => 10/917517
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15717
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917517 | Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer | Aug 12, 2004 | Abandoned |
Array
(
[id] => 5216033
[patent_doc_number] => 20070105114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Biomarkers of cyclin-dependent kinase modulation'
[patent_app_type] => utility
[patent_app_number] => 10/567867
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 37656
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567867 | Biomarkers of cyclin-dependent kinase modulation | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7250320
[patent_doc_number] => 20050074452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/894672
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13407
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894672 | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof | Jul 19, 2004 | Issued |
Array
(
[id] => 6905148
[patent_doc_number] => 20050100543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Multivalent carriers of bi-specific antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/882151
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 52916
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10882151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/882151 | Multivalent carriers of bi-specific antibodies | Jun 30, 2004 | Abandoned |
Array
(
[id] => 5074827
[patent_doc_number] => 20070014802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Modified antibody fragments'
[patent_app_type] => utility
[patent_app_number] => 10/562769
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10716
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562769 | Modified antibody fragments | Jun 30, 2004 | Abandoned |
Array
(
[id] => 5056379
[patent_doc_number] => 20070059301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Modified antibody fragments'
[patent_app_type] => utility
[patent_app_number] => 10/562807
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10359
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562807 | Modified antibody fragments | Jun 30, 2004 | Abandoned |
Array
(
[id] => 5045602
[patent_doc_number] => 20070264275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 10/561951
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3260
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264275.pdf
[firstpage_image] =>[orig_patent_app_number] => 10561951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/561951 | Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy | Jun 23, 2004 | Issued |
Array
(
[id] => 5894454
[patent_doc_number] => 20060002993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/859643
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 73529
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10859643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/859643 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Jun 1, 2004 | Issued |
Array
(
[id] => 5142697
[patent_doc_number] => 20070004913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/860769
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 73639
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860769 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Jun 1, 2004 | Issued |
Array
(
[id] => 5119936
[patent_doc_number] => 20070141650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Predicting cancer progression'
[patent_app_type] => utility
[patent_app_number] => 10/555935
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9472
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141650.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555935 | Predicting cancer progression | May 13, 2004 | Abandoned |
Array
(
[id] => 239426
[patent_doc_number] => 07592143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Methods of treating diseases responsive to induction of apoptosis and screening assays'
[patent_app_type] => utility
[patent_app_number] => 10/826909
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 56458
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826909 | Methods of treating diseases responsive to induction of apoptosis and screening assays | Apr 18, 2004 | Issued |
Array
(
[id] => 4959685
[patent_doc_number] => 20080274110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Cell Death-Inducing Agents'
[patent_app_type] => utility
[patent_app_number] => 11/547747
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 15030
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274110.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547747
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547747 | Cell Death-Inducing Agents | Apr 8, 2004 | Abandoned |
Array
(
[id] => 7297254
[patent_doc_number] => 20040214788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Treatment of prostate cancer'
[patent_app_type] => new
[patent_app_number] => 10/797690
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9573
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214788.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797690
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797690 | Treatment of prostate cancer | Mar 9, 2004 | Abandoned |
Array
(
[id] => 7152580
[patent_doc_number] => 20050025771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Antitumor agents comprising a targeting portion and an immune response triggering portion'
[patent_app_type] => utility
[patent_app_number] => 10/792390
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9654
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20050025771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792390 | Antitumor agents comprising a targeting portion and an immune response triggering portion | Mar 3, 2004 | Abandoned |
Array
(
[id] => 5742813
[patent_doc_number] => 20060088538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical composition, and diagnostic reagent'
[patent_app_type] => utility
[patent_app_number] => 10/546594
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14252
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546594 | Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical composition, and diagnostic reagent | Feb 26, 2004 | Issued |
Array
(
[id] => 895739
[patent_doc_number] => 07342105
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'Antibody and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/547051
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17246
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/342/07342105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547051
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547051 | Antibody and use thereof | Feb 25, 2004 | Issued |